Difficulty: Medium
Average Score: 92%
Practice
The following poses the least risk of adverse cardiovascular events
Correct answer
A
Rationale
In the context of pharmacology, understanding the cardiovascular risks associated with nonsteroidal anti-inflammatory drugs (NSAIDs) is crucial. In this case, the correct answer is A) Naproxen, as it is known to pose the least risk of adverse cardiovascular events among the options provided.
Naproxen is considered safer in terms of cardiovascular outcomes compared to other NSAIDs due to its relatively lower impact on blood pressure, clotting factors, and overall cardiovascular health. It has been associated with a lower incidence of cardiovascular events such as heart attacks and strokes compared to other NSAIDs.
On the other hand, options B, C, and D (Piroxicam, Diclofenac, Indomethacin) are known to have a higher risk of adverse cardiovascular events. Piroxicam and Diclofenac, for example, have been associated with an increased risk of cardiovascular events such as heart attacks and strokes. Indomethacin is also known to have a higher risk of adverse cardiovascular effects compared to Naproxen.
In an educational context, this question highlights the importance of considering the cardiovascular safety profiles of different NSAIDs when prescribing these medications to patients, especially those with pre-existing cardiovascular conditions. Healthcare providers need to weigh the risks and benefits of NSAIDs carefully to make informed decisions that minimize potential harm to patients. This knowledge is essential for healthcare professionals, particularly prescribers, to ensure patient safety and optimize clinical outcomes.
Naproxen is considered safer in terms of cardiovascular outcomes compared to other NSAIDs due to its relatively lower impact on blood pressure, clotting factors, and overall cardiovascular health. It has been associated with a lower incidence of cardiovascular events such as heart attacks and strokes compared to other NSAIDs.
On the other hand, options B, C, and D (Piroxicam, Diclofenac, Indomethacin) are known to have a higher risk of adverse cardiovascular events. Piroxicam and Diclofenac, for example, have been associated with an increased risk of cardiovascular events such as heart attacks and strokes. Indomethacin is also known to have a higher risk of adverse cardiovascular effects compared to Naproxen.
In an educational context, this question highlights the importance of considering the cardiovascular safety profiles of different NSAIDs when prescribing these medications to patients, especially those with pre-existing cardiovascular conditions. Healthcare providers need to weigh the risks and benefits of NSAIDs carefully to make informed decisions that minimize potential harm to patients. This knowledge is essential for healthcare professionals, particularly prescribers, to ensure patient safety and optimize clinical outcomes.